Antiangiogenic and immunomodulatory effects of metronomic cyclophosphamide (CPM) treatment in prostate cancer patients with PSA failure

Affiliation auteurs!!!! Error affiliation !!!!
TitreAntiangiogenic and immunomodulatory effects of metronomic cyclophosphamide (CPM) treatment in prostate cancer patients with PSA failure
Type de publicationJournal Article
Year of Publication2014
AuteursAdotevi O, Calcagno F, Maurina T, Kim S, Thiery-Vuillemin A, Borg C, Godet Y, Laheurte C
JournalCANCER RESEARCH
Volume74
Date PublishedOCT 1
Type of ArticleMeeting Abstract
ISSN0008-5472
DOI10.1158/1538-7445.AM2014-2588